Stay updated on DICIPLE: Dual Checkpoint Inhibitors in NSCLC Clinical Trial

Sign up to get notified when there's something new on the DICIPLE: Dual Checkpoint Inhibitors in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the DICIPLE: Dual Checkpoint Inhibitors in NSCLC Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The website has been updated from version v2.14.1 to v2.14.2.
    Difference
    0.1%
    Check dated 2025-02-03T08:31:55.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    The website has been updated from version 2.14.0 to 2.14.1.
    Difference
    0.1%
    Check dated 2025-01-19T22:24:11.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    The website has updated the 'type of intervention' feature from version v2.13.3 to v2.14.0, indicating a significant change in its functionality.
    Difference
    0.2%
    Check dated 2025-01-12T17:51:38.000Z thumbnail image
  5. Check
    52 days ago
    Change Detected
    Summary
    The website has been updated from version 2.13.2 to 2.13.3, indicating a new release.
    Difference
    0.1%
    Check dated 2024-12-14T22:40:57.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    The website has updated the contact details section for the study, clarifying that it now provides information for individuals who can answer questions about joining the study and includes a reference to the Contacts and Locations section.
    Difference
    2%
    Check dated 2024-12-07T15:59:37.000Z thumbnail image
  7. Check
    74 days ago
    Change Detected
    Summary
    Several key URLs related to genetics, lung cancer, and clinical studies have been removed, indicating a significant reduction in available resources on these topics.
    Difference
    4%
    Check dated 2024-11-23T04:29:59.000Z thumbnail image

Stay in the know with updates to DICIPLE: Dual Checkpoint Inhibitors in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the DICIPLE: Dual Checkpoint Inhibitors in NSCLC Clinical Trial page.